Collegium Pharmaceutical (COLL) Share-based Compensation Growth (1y) (2015 - 2026)
Collegium Pharmaceutical (COLL) Share-based Compensation Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Collegium Pharmaceutical | 891.70 Mn | 742.38 Mn | 110.29 Mn | -87.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -87.05% |
| Mar 31, 2026 | 45.69% |
| Dec 31, 2025 | 121.49% |
| Sep 30, 2025 | 22.31% |
| Jun 30, 2025 | 46.72% |
| Mar 31, 2025 | -17.72% |
| Dec 31, 2024 | -28.93% |
| Sep 30, 2024 | 670.81% |
| Jun 30, 2024 | 639.34% |
| Mar 31, 2024 | 113.32% |
| Dec 31, 2023 | 244.44% |
| Sep 30, 2023 | 30.69% |
| Jun 30, 2023 | 24.24% |
| Mar 31, 2023 | -1.63% |
| Dec 31, 2022 | -367.92% |
| Sep 30, 2022 | -9.60% |
| Jun 30, 2022 | -12.65% |
| Mar 31, 2022 | -10.82% |
| Dec 31, 2021 | 442.16% |
| Sep 30, 2021 | 15.16% |